Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)583-584
Number of pages2
JournalUrologic Oncology: Seminars and Original Investigations
Volume27
Issue number6
DOIs
StatePublished - Nov 2009

Fingerprint

Sentinel Surveillance
False Positive Reactions
Predictive Value of Tests
Mass Screening
Prostate-Specific Antigen
Diagnostic Errors
Disease Progression
Prostatic Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

@article{5aaa74256259477fa1a3322fd3a5957c,
title = "Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer",
author = "Stacy Loeb and Carter, {H Ballentine}",
year = "2009",
month = "11",
doi = "10.1016/j.urolonc.2009.06.011",
language = "English (US)",
volume = "27",
pages = "583--584",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer

AU - Loeb, Stacy

AU - Carter, H Ballentine

PY - 2009/11

Y1 - 2009/11

UR - http://www.scopus.com/inward/record.url?scp=70350511394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350511394&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2009.06.011

DO - 10.1016/j.urolonc.2009.06.011

M3 - Article

VL - 27

SP - 583

EP - 584

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 6

ER -